• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Maase (MAAS) Looks Pricey On A 13.9x P B Multiple

    Simply Wall St·08/22/2026 10:15:47
    Listen to the news

    Maase (MAAS) drew fresh attention after its US listing on the NasdaqGM, with investors weighing a US$15.63 share price against a roughly US$6.91b market value and an AI focused, loss making business model.

    See our latest analysis for Maase.

    Since listing on Nasdaq, Maase has seen sharp swings, with a 1 day share price return close to flat, a softer 7 and 30 day share price return, yet a strong year to date share price return of 168.24% that points to momentum still building despite recent pullbacks.

    If this kind of AI focused volatility has your attention, it may be worth broadening your watchlist with other opportunities in the same space using our 76 profitable AI stocks that aren't just burning cash.

    After a rapid year to date move, Maase now trades around US$15.63 on a roughly US$6.91b market value. Is it better to step in after this run, or wait for clearer value support in the numbers ahead?

    Price to book of 13.9x for Maase: Is it justified?

    On the latest data, Maase trades on a P/B of 13.9x, which is significantly higher than both its peer group at 6.5x and the broader US Insurance industry at 1.6x.

    The P/B ratio compares a company’s market value to its book value, essentially what investors are paying for each dollar of net assets on the balance sheet. For an early stage, loss making AI operator with limited reported revenue, a high P/B often reflects expectations about future monetisation of its technology and services rather than current profitability.

    Here, Maase is loss making with revenue of $6.62m and a reported net loss of $21.72m, yet carries a roughly $6.91b market value. That gap, combined with a P/B that is more than double the peer average and much higher than the wider industry, suggests investors are currently assigning a premium price tag to its AI centric model even before profits or larger scale revenue arrive.

    Compared with the US Insurance industry P/B of 1.6x, Maase’s 13.9x multiple is very elevated and points to a valuation that prices in expectations far above what is reflected in present balance sheet metrics.

    See what the numbers say about this price — find out in our valuation breakdown.

    Result: Price-to-book of 13.9x (OVERVALUED)

    However, Maase’s high P/B, compared with modest revenue of US$6.62m and a net loss of US$21.72m, means any slowdown in AI adoption or funding appetite could quickly challenge this valuation.

    Find out about the key risks to this Maase narrative.

    Next Steps

    With Maase attracting mixed reactions around risk and potential reward, it makes sense to review the full picture yourself and decide quickly where you stand. To weigh up both sides of the story, start by looking through the 1 key reward and 4 important warning signs.

    Looking for more investment ideas beyond Maase?

    If Maase has sharpened your focus on where risk and potential return meet, do not stop here. Fresh ideas often come from comparing very different types of stocks.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.